跳至主要内容
临床试验/IRCT20110310006026N11
IRCT20110310006026N11招募中2 期

Evaluation of the effects of standardized hydroalcoholic extract of rosemary (Rosmarinus officinalis L.) capsule as adjunctive treatment in major depressive disorder

Kerman University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Outpatient with Major Depression Based on DSM-5 Criterion, 18-55 years old, depressed patient who has never been on medication and is a candidate for SSRI treatment.

排除标准

  • Pregnancy, lactation, having underlying medical or psychiatric illnesses, hypersensitivity reactions to rosemary, people at high risk of suicide, mental retardation - dependence on a variety of substances

研究者

相似试验

Evaluating the effects of rosemary capsule as... | 临床试验